HomePCSA • NASDAQ
add
Processa Pharmaceuticals Inc
Previous close
$0.25
Day range
$0.25 - $0.27
Year range
$0.15 - $1.50
Market cap
14.67M USD
Avg Volume
3.82M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.49M | 1.87% |
Net income | -3.44M | -1.53% |
Net profit margin | — | — |
Earnings per share | -0.07 | 93.20% |
EBITDA | -3.49M | -1.87% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.31M | 118.17% |
Total assets | 7.58M | 53.47% |
Total liabilities | 1.75M | 43.36% |
Total equity | 5.83M | — |
Shares outstanding | 56.64M | — |
Price to book | 2.29 | — |
Return on assets | -110.64% | — |
Return on capital | -145.78% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -3.44M | -1.53% |
Cash from operations | -3.48M | 3.28% |
Cash from investing | — | — |
Cash from financing | 2.86M | 208.38% |
Net change in cash | -628.20K | 76.56% |
Free cash flow | -2.24M | 5.37% |
About
Founded
2011
Headquarters
Website
Employees
10
